BrainStorm Cell Therapeutics Inc., of New York, named Moshe Lion to its board of directors.
Cerenis Therapeutics SA, of Toulouse, France, appointed Narendra D. Lalwani chief scientific officer and John Wetterau vice president of pharmacology.
CV Therapeutics Inc., of Palo Alto, Calif., named Lewis Stuart senior vice president of commercial operations.
Diamics Inc., of Novato, Calif., appointed Piush Vidyarthi vice president of operations and business development.
Ensemble Discovery Corp., of Cambridge, Mass., appointed David J. Livingston, senior vice president of biology.
EyeGate Pharma, of Waltham, Mass., named of Michael A. Patane vice president of research and development and named Michael P. Manzo vice president of engineering.
GeneGo Inc., of St. Joseph, Mich., appointed Richard Brennan director of toxicology.
GeneNews Ltd., of Toronto, named Bernard Levin chair of its colorectal cancer clinical advisory board.
Genstruct Inc., of Cambridge, Mass., appointed Christopher Z. Thomajan chief financial officer.
Halozyme Therapeutics Inc., of San Diego, named Walter Bee vice president of preclinical development.
Keryx Biopharmaceuticals Inc., of New York, appointed William P. Kane vice president of commercial operations.
Lorus Therapeutics Inc., of Toronto, named Herbert Abramson to its board of directors.
Luminex Corp., of Austin, Texas, appointed Douglas C. Bryant executive vice president and chief operating officer.
Merrimack Pharmaceuticals Inc., of Cambridge, Mass., named William Slichenmyer senior vice president and chief medical officer.
Micromet Inc., of Bethesda, Md., appointed Carsten Reinhardt senior vice president and chief medical officer.
MPM BioEquities, of New York, named David Molowa, general partner.
NanoBio Corp., of Ann Arbor, Mich., appointed Jerald C. Sadoff to its scientific advisory board.
NPS Pharmaceuticals Inc., of Parsippany, N.J., named Andrew Rackear associate general counsel.
Phenomix Corp., of San Diego, appointed James Harper and William Harris to its board of directors.
Probiodrug AG, of Munich, Germany, named Hendrik Liebers chief financial officer.
Safeguard Scientifics Inc., of Wayne, Pa., appointed Raymond J. Land senior vice president and chief financial officer.
Shamrock Structures LLC, of Chicago, named Richard L. Walter chief scientific officer.
Spectrum Pharmaceuticals Inc., of Irvine, Calif., appointed Mitchell P. Cybulski to its board of directors.
UCB, of Brussels, named Detlef Thielgen chief financial officer.